Spruce Biosciences Stock Forward View - Price Action Indicator
| SPRB Stock | USD 66.29 16.67 20.09% |
Spruce Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Spruce Biosciences stock prices and determine the direction of Spruce Biosciences Common's future trends based on various well-known forecasting models. We suggest always using this module together with an analysis of Spruce Biosciences' historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time the rsi of Spruce Biosciences' share price is below 20 . This usually implies that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (5.90) | EPS Estimate Current Year (40.49) | EPS Estimate Next Year (6.49) | Wall Street Target Price 230.5 | EPS Estimate Current Quarter (12.31) |
Using Spruce Biosciences hype-based prediction, you can estimate the value of Spruce Biosciences Common from the perspective of Spruce Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
Spruce Biosciences after-hype prediction price | USD 66.29 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Spruce Biosciences to cross-verify your projections. Spruce Biosciences Additional Predictive Modules
Most predictive techniques to examine Spruce price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Spruce using various technical indicators. When you analyze Spruce charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Price Action Indicator | Price Action Indicator | Trend |
| (15.40) | (16.85) |
| Check Spruce Biosciences Volatility | Backtest Spruce Biosciences | Information Ratio |
Spruce Biosciences Trading Date Momentum
| On February 16 2026 Spruce Biosciences Common was traded for 66.29 at the closing time. The top price for the day was 83.54 and the lowest listed price was 66.08 . There was no trading activity during the period 0.0. Lack of trading volume on February 16, 2026 did not result in any price rise and fall. The trading price change against the current closing price is 20.76% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare Spruce Biosciences to competition |
Other Forecasting Options for Spruce Biosciences
For every potential investor in Spruce, whether a beginner or expert, Spruce Biosciences' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Spruce Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Spruce. Basic forecasting techniques help filter out the noise by identifying Spruce Biosciences' price trends.Spruce Biosciences Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Spruce Biosciences stock to make a market-neutral strategy. Peer analysis of Spruce Biosciences could also be used in its relative valuation, which is a method of valuing Spruce Biosciences by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Spruce Biosciences Market Strength Events
Market strength indicators help investors to evaluate how Spruce Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Spruce Biosciences shares will generate the highest return on investment. By undertsting and applying Spruce Biosciences stock market strength indicators, traders can identify Spruce Biosciences Common entry and exit signals to maximize returns.
Spruce Biosciences Risk Indicators
The analysis of Spruce Biosciences' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Spruce Biosciences' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting spruce stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.91 | |||
| Standard Deviation | 6.41 | |||
| Variance | 41.12 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Spruce Biosciences
The number of cover stories for Spruce Biosciences depends on current market conditions and Spruce Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Spruce Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Spruce Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Spruce Biosciences Short Properties
Spruce Biosciences' future price predictability will typically decrease when Spruce Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Spruce Biosciences Common often depends not only on the future outlook of the potential Spruce Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Spruce Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 536.4 K | |
| Cash And Short Term Investments | 38.8 M |
Check out Historical Fundamental Analysis of Spruce Biosciences to cross-verify your projections. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Spruce Biosciences. If investors know Spruce will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Spruce Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (84.32) | Revenue Per Share | Quarterly Revenue Growth (0.76) | Return On Assets | Return On Equity |
Understanding Spruce Biosciences Common requires distinguishing between market price and book value, where the latter reflects Spruce's accounting equity. The concept of intrinsic value - what Spruce Biosciences' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Spruce Biosciences' price substantially above or below its fundamental value.
Please note, there is a significant difference between Spruce Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Spruce Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Spruce Biosciences' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.